Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
NCT05981105

Enhanced Recovery After Major Surgery and Chronic Pain for Total Knee Arthroplasty

Led by Hospital for Special Surgery, New York · Updated on 2026-01-15

64

Participants Needed

1

Research Sites

185 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this interventional clinical trial is to assess opioid consumption 24-48 hrs post anesthesia block among patients undergoing total knee arthroplasty. The main question it aims to answer is: 1\. Is there a difference in opioid consumption 24-48 hours post block administration among patients that receive an adductor canal catheter (ACC) versus adductor canal block (ACB)? Participants will be: * Randomized to receive an adductor canal catheter (ACC) or a sham adductor canal catheter. * Asked to use the Diagnotes application to communicate with the pain doctor while the catheter is in place. * Follow up for up to 6 months post-operation. Researchers will compare the interventional group (ACC) to the control group (sham ACC + ACB) to see if there is difference in opioid consumption and chronic pain at 6 months post-operation.

CONDITIONS

Official Title

Enhanced Recovery After Major Surgery and Chronic Pain for Total Knee Arthroplasty

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with osteoarthritis scheduled for a primary total knee arthroplasty with a participating surgeon
  • Age 18 to 75 years
  • Planned use of regional anesthesia
  • Ability to follow study protocol
  • English speaking
  • Patients of participating surgeons: Drs. Mayman, Jerabek, Westrich, Su, Della Valle, Alexiades
  • Lives within one hour of the hospital
  • Has a smartphone
Not Eligible

You will not qualify if you...

  • Hepatic or renal insufficiency
  • Younger than 18 years old and older than 65
  • Patients undergoing general anesthesia
  • Allergy or intolerance to one of the study medications
  • BMI greater than 40
  • Diabetes
  • ASA of III or IV
  • Chronic gabapentin or pregabalin use for longer than 3 months
  • Pain Catastrophizing Scale (PCS) score greater than 30
  • Chronic opioid use (longer than 3 months or daily oral morphine equivalent over 5 mg/day for one month)
  • Severe valgus deformity or flexion contracture
  • Unable to follow home catheter instructions or unwilling to go home with an infusing catheter
  • No home caregivers if catheter sent home
  • Planned stay at a rehabilitation facility

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hospital for Special Surgery

New York, New York, United States, 10021

Actively Recruiting

Loading map...

Research Team

P

Pa Thor, PhD

CONTACT

S

Stavros Memtsoudis, MD/PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here